Heidi Arrives at HIMSS26 with R1 Partnership and a Platform Built Beyond the Scribe

Key Takeaways

• R1 partnership integrates clinical notes with real‑time payer data
• Platform supports 2.7 million weekly visits across 200 specialties
• Evidence tool provides ad‑free, citation‑backed decision support
• Adoption driven by physicians, achieving 60‑80% weekly activation
• Heidi expands beyond physicians to nurses and other clinicians

Summary

Heidi used HIMSS26 to unveil its biggest product and partnership moves since launching its ambient AI scribe, announcing a revenue‑cycle integration with R1 and a new clinical‑evidence tool called Evidence. The company says the platform now handles over 2.7 million visits weekly across more than 200 specialties and is deployed in nearly every country. Integration with Epic, Cerner and Athena underpins a “AI Care Partner” strategy that spans documentation, decision support and patient communications. Heidi’s growth is driven by physician‑led adoption rather than traditional IT‑centric sales.

Pulse Analysis

The ambient AI documentation market has accelerated dramatically since 2022, with vendors racing to embed conversational assistants into clinicians' workflows. Heidi, founded in 2024, has positioned itself beyond a simple scribe by layering decision‑support and communication capabilities onto its core platform. This modular approach allows the system to function independently of any single EHR, yet deep integrations with Epic, Cerner and Athena ensure data fidelity for large health systems. By supporting more than 2.7 million weekly encounters across 200 specialties, Heidi demonstrates a scale that rivals legacy players while maintaining specialty‑specific configurability.

Heidi’s headline partnership with R1 marks a strategic shift toward a "care‑to‑cash" operating model. By feeding real‑time payer policies, prior‑authorization rules and eligibility data directly into the documentation flow, clinicians receive billing guidance at the point of care, reducing down‑coding and missed charges. For providers, this translates into faster claim cycles, higher reimbursement predictability, and a measurable reduction in administrative overhead—an advantage that could sway the roughly 1,000 provider organizations already using R1. In a market where revenue‑cycle silos cost U.S. health systems billions annually, such integration offers a compelling competitive moat.

The launch of Evidence, an ad‑free clinical decision‑support engine built on Anthropic’s Claude models, adds another layer of value. By surfacing peer‑reviewed research and guideline citations in real time, the tool helps clinicians make evidence‑based choices without leaving the encounter. Heidi’s growth model—driven by individual physicians rather than top‑down IT mandates—has yielded activation rates of 60‑80% and returned an estimated eight million clinician hours annually. As the platform expands to nurses, pharmacists and radiologists, its global footprint and specialty depth position it to shape the next wave of AI‑augmented care delivery worldwide.